← back to search

Jiangtao Lin

North Sichuan Medical University · CN
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Asthma, Medicine, Exacerbation, Internal medicine, Asthma management, and Formoterol.
h-index
citations
1,431
works
20
NIH funding
primary concept
email

Recent publications

[A multicenter, prospective, observational study of cough variant asthma in China: clinical features, airway inflammation, and prognosis].
PubMed 2025cited by 0position: middledoi
Identification of cough-variant asthma phenotypes based on clinical and pathophysiologic data
Journal of Allergy and Clinical Immunology 2023cited by 26position: middledoi
Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway
Frontiers in Pharmacology 2023cited by 20position: middledoi
Role of clinical biomarkers in predicting the effectiveness of omalizumab
Therapeutic Advances in Respiratory Disease 2023cited by 8position: lastdoi
[Influencing factors of poor treatment adherence in uncontrolled asthma patients in China].
PubMed 2023cited by 0position: middledoi
Associations between ICS-based maintenance treatment and asthma outcome (asthma control, asthma exacerbation hospitalization and emergency department visit) in real world: data from CARN study 
Research Square 2023cited by 0position: middledoi
Asthma Management Using the Mobile Asthma Evaluation and Management System in China
Allergy Asthma and Immunology Research 2022cited by 10position: firstdoi
Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study
BMC Pulmonary Medicine 2022cited by 7position: middledoi
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
European Respiratory Journal 2021cited by 536position: middledoi
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 128position: middledoi
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes
Archivos de Bronconeumología 2021cited by 68position: middledoi
Global Initiative for Asthma Strategy 2021
Respirology 2021cited by 50position: middledoi
Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma
BMC Pulmonary Medicine 2020cited by 5position: firstdoi
GINA 2019: a fundamental change in asthma management
European Respiratory Journal 2019cited by 382position: middledoi
Multi-city study on air pollution and hospital outpatient visits for asthma in China
Environmental Pollution 2019cited by 73position: middledoi
INITIAL – An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks’ treatment
Scientific Reports 2019cited by 8position: firstdoi
[Seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China].
PubMed 2018cited by 2position: firstdoi
The changes of asthma control and management, patients’perception for the past decade in China
2018cited by 0position: firstdoi
Attributable risks of emergency hospital visits due to air pollutants in China: A multi-city study
Environmental Pollution 2017cited by 72position: middledoi
Real world evaluation of asthma control risk factors and management: findings from China national asthma control surveys
2017cited by 1position: middledoi
Evaluation of asthma control: a questionnaire-based survey in China
Chinese Medical Journal 2014cited by 7position: middledoi
Evaluation of asthma control and patient’s perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China
Journal of Asthma 2013cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guy Brusselle · University of Colorado Denver5 papers (2019–2021)Helen K. Reddel · New South Wales Department of Health5 papers (2019–2021)Louise Fleming · Imperial College Healthcare NHS Trust5 papers (2019–2021)Aziz Sheikh · National Institute of Technology Srinagar5 papers (2019–2021)J. Mark FitzGerald · Vancouver Coastal Health5 papers (2019–2021) · 5 papers (2019–2021)Roland Buhl · Johannes Gutenberg University Mainz5 papers (2019–2021)Arzu Yorgancıoğlu · Medical University of Warsaw5 papers (2019–2021)Mark L Levy · University of Edinburgh5 papers (2019–2021)Leonard B. Bacharier · University of Illinois Chicago5 papers (2019–2021)Álvaro A. Cruz · Universidade Federal da Bahia5 papers (2019–2021)Jerry A. Krishnan · IIT Research Institute5 papers (2019–2021)Fanny W.S. Ko · Icahn School of Medicine at Mount Sinai5 papers (2019–2021)Louis‐Philippe Boulet · University of Cape Town5 papers (2019–2021)Eric D. Bateman · University of Cape Town5 papers (2019–2021)Jeffrey M. Drazen · Harvard University4 papers (2021–2021)Yadong Yuan · Hebei Medical University4 papers (2013–2023)Christopher E. Brightling · University of Leicester4 papers (2021–2021)Liesbeth Duijts · Ludwig-Maximilians-Universität München4 papers (2021–2021) · 4 papers (2021–2021)